1'756 companies found
Avrion Therapeutics SA
Lausanne · Since 2020
The core activity of Avrion Tx is the development of gene therapies, particularly for the treatment of rare diseases and specific forms of blindness.
Axalbion SA
Lausanne · Since 2021
Axalbion SA is a clinical-stage biopharmaceutical company developing TRPM8 agonists. Its lead candidate AX-8 is being developed for topical treatment of refractory chronic cough and dry eye syndrome.
AxCellerate Sagl
Agno · Since 2023
AxCellerate Sagl provides contract research services based on a proprietary platform that integrates microelectrode arrays (MEAs) and glass microfluidics to study 3D neuronal models for disease modeling, target validation, and preclinical efficacy and safety testing.
Azafaros Switzerland AG
Basel · Since 2020
The company's core activity is the development and marketing of pharmaceuticals, particularly in the field of rare diseases and oncology. The company is involved in clinical development, regulatory affairs and the distribution of medicines, as well as strategic planning and management of business relationships in the pharmaceutical industry.
AZAD Pharma AG
Schaffhausen · Since 2003
The core activity of AZAD is the development and manufacturing of generic active pharmaceutical ingredients (APIs) and finished products for the pharmaceutical industry.
Baccinex S.A.
Courroux · Since 1999
Adragos Pharma is a contract development and manufacturing organization (CDMO) for pharmaceutical products. The company's core activity encompasses the development, manufacture and analysis of (bio)pharmaceutical products, including sterile and non-sterile liquids, semi-solids, tablets and suppositories. The company also offers services such as inspection, packaging, storage and distribution of pharmaceutical products.
Bailleul (Suisse) SA
Geneva · Since 2014
Bailleul (Suisse) SA is a pharmaceutical company specializing in the development and commercialization of medicinal products, dietary supplements and dermo‑cosmetic products.
Baliopharm AG
Reinach Bl · Since 2007
Baliopharm AG is a biotechnology company developing antibody therapeutics for chronic liver diseases, immune-mediated inflammatory diseases and oncology. Its portfolio includes monoclonal antibodies and antibody-derived formats such as monovalent and bispecific constructs designed for targeted selectivity.
Basilea Pharmaceutica International AG, Allschwil
Allschwil · Since 2008
Basilea Pharmaceutica International AG, Allschwil develops and commercializes pharmaceutical products focused on anti-infectives, particularly antifungal and antibiotic therapies. The company’s portfolio includes Cresemba (isavuconazole) and Zevtera (ceftobiprole), and it maintains clinical and preclinical programs for additional anti-infective candidates.
Basilea Pharmaceutica AG, Allschwil
Allschwil · Since 2002
Basilea Pharmaceutica AG, Allschwil is a pharmaceutical company that develops and commercializes medicines for severe and life‑threatening bacterial and fungal infections. Its portfolio includes antifungal and antibacterial products such as Cresemba (isavuconazole) and Zevtera.
Bavarian Nordic Berna GmbH
Thörishaus · Since 2014
The core activity of Bavarian Nordic is the research, development and production of innovative, life-saving vaccines.
Baxalta Manufacturing Sàrl
Neuchâtel · Since 2003
Baxalta Manufacturing Sàrl is listed on Takeda's website as a company associated with the Takeda production site. The production site manufactures biotechnologically produced medicines for bleeding disorders, including recombinant factor VIII and recombinant von Willebrand factor.
BAXTER Group AG
Visp · Since 2009
BAXTER Group AG is a healthcare company that supplies medical devices, injectable medicines and clinical nutrition products for hospital, renal and surgical care.
BeOne Medicines International GmbH
Basel · Since 2020
BeOne Medicines International GmbH is a biopharmaceutical company that conducts research, development and clinical trials for cancer medicines targeting hematologic malignancies and solid tumors. The company develops an oncology pipeline, runs global clinical studies and collaborates with partners on regulatory approval, manufacturing and distribution of its therapies.
BeOne Medicines I GmbH
Basel · Since 2017
BeOne Medicines I GmbH researches, develops and commercializes oncology medicines and runs global clinical trials across hematologic and solid tumor indications; publicly referenced products include zanubrutinib (BRUKINSA), tislelizumab (TEVIMBRA) and pamiparib.
BeOne Medicines Pharmaceuticals GmbH
Basel · Since 2020
BeOne Medicines Pharmaceuticals GmbH develops and researches medicines for the treatment of cancer and advances them through clinical development. Its pipeline spans clinical and commercial-stage assets across hematologic and solid tumor indications and explores modalities including small molecules, protein degraders (CDACs), monoclonal and bi-/multi‑specific antibodies, antibody‑drug conjugates, cell therapies and cytokine approaches.
Benemedo GmbH
Lachen Sz · Since 2010
Benemedo GmbH is a pharmaceutical and cosmetics company specializing in the development, manufacture and marketing of its own product lines. The company's core activity encompasses the production and distribution of pharmaceuticals and cosmetics, particularly under the brands Vitella, Mediket, Benevet and Benemedio. The company works closely with partners from the pharmaceutical industry and has a strong presence in Europe, North America and Asia.
BEO Therapeutics AG
Zurich · Since 2019
BEO Therapeutics AG develops oral microbiome therapies to counteract diseases caused by metabolic waste products, such as gouty arthritis and (cardio-)metabolic disorders. The company focuses on QPS‑designated bacteria to rebalance the gut microbiome and is evaluating BEO 001 in phase 1/2 clinical trials in patients with hyperuricemia.
BHP Bio Health Pharma AG
Hergiswil Nw · Since 2001
The core activity of BHP Bio Health Pharma AG is investing in the Ukrainian healthcare and hygiene sector, particularly through participations in companies specialized in the production of disinfectants, medical services and hospital management.
Bial SA
Nyon · Since 2018
The core activity of BIAL is the development, manufacture and marketing of medicines and therapeutic solutions in the healthcare sector. The company focuses particularly on research and development of new medicines and therapies to improve the quality of life of people worldwide.
Outbound Leads by COHAGALeadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Discover LeadhubHow the search works, what each filter means, and how the results come together.
Source: Federal Statistical Office, UID register